academic institutionsChinalung cancerhepatocellular carcinomaleukemiaInformadendritic cell-CIK therapymalignanciescytokine-induced killer (CIK) cell therapyautoimmune and inflammatory diseases
…arly-phase studies, with China leading clinical translation and academic institutions as primary sponsors. Oncology trials are most frequent, particu…